Development of SARS-CoV-2 Nucleocapsid Specific Monoclonal Antibodies

The global COVID-19 pandemic has caused massive disruptions in every society around the world. To help fight COVID-19, new molecular tools specifically targeting critical components of the causative agent of COVID-19, SARS-Coronavirus-2 (SARS-CoV-2), are desperately needed. The SARS-CoV-2 nucleocaps...

Descripción completa

Detalles Bibliográficos
Autores principales: Terry, James S., Anderson, Loran BR, Scherman, Michael S., McAlister, Carley E., Perera, Rushika, Schountz, Tony, Geiss, Brian J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480041/
https://www.ncbi.nlm.nih.gov/pubmed/32908982
http://dx.doi.org/10.1101/2020.09.03.280370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480041/
https://www.ncbi.nlm.nih.gov/pubmed/32908982
http://dx.doi.org/10.1101/2020.09.03.280370

Ejemplares similares